IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding IO Biotech, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 20 | +20 |
| Shares | 0 | 15.0M | +15.0M |
| Value | $0 | $92.6M | +$92.6M |
New holders (20)
Institutions that held IO Biotech, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Novo Holdings A/S | 3,277,932 | $21.0M | 0.99% |
| Vivo Capital, LLC | 3,015,545 | $19.3M | 1.16% |
| Ra Capital Management, L.P. | 1,857,755 | $11.9M | 0.21% |
| Avoro Capital Advisors LLC | 2,055,883 | $10.2M | 0.17% |
| Capital World Investors | 1,235,000 | $8.11M | 0.00% |
| PFM Health Sciences, LP | 1,362,144 | $7.74M | 0.27% |
| Samsara BioCapital, LLC | 1,120,437 | $7.17M | 1.43% |
| Soleus Capital Management, L.P. | 672,734 | $4.30M | 0.58% |
| Vanguard Group Inc | 205,200 | $1.31M | 0.00% |
| Millennium Management LLC | 77,963 | $512.0K | 0.00% |
| Caas Capital Management LP | 50,479 | $323.0K | 0.03% |
| Norges Bank | 25,000 | $164.0K | 0.00% |
| Squarepoint Ops LLC | 14,966 | $98.0K | 0.00% |
| Citadel Advisors LLC | 13,060 | $86.0K | 0.00% |
| Virtu Financial LLC | 12,665 | $83.0K | 0.01% |
| Geode Capital Management, LLC | 11,173 | $73.0K | 0.00% |
| Bank of America Corp | 10,000 | $64.0K | 0.00% |
| Stifel Financial Corp | 10,000 | $64.0K | 0.00% |
| Morgan Stanley | 8,958 | $57.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,572 | $10.0K | 0.00% |
Sold out (0)
Institutions that held IO Biotech, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.